Top Story

FDA clears IND application for natural killer cell therapy for glioblastoma multiforme

January 22, 2020
Meeting NewsPerspective

Sociodemographic factors may influence survival among young adults with colorectal cancer

January 22, 2020
Young adults with colorectal cancer who resided in areas with the lowest incomes and high school graduation rates had a 24% increased risk for death than their…
Meeting News

Atezolizumab-bevacizumab combination delays quality-of-life deterioration in hepatocellular carcinoma

January 22, 2020
Atezolizumab in combination with bevacizumab delayed time to deterioration of quality of life, physical functioning and role functioning compared with standard-of-care…

Tislelizumab extends PFS in squamous non-small cell lung cancer

January 22, 2020
A randomized phase 3 trial designed to evaluate the addition of tislelizumab to first-line chemotherapy for patients with squamous non-small cell lung cancer met its…

Recommendations seek ‘similarity across trials’ of therapies for sickle cell disease

January 22, 2020
Sickle cell disease, the most common inherited red blood cell disorder in the United States, is associated with debilitating physical symptoms, including
More Headlines »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next